CellaVision AB (publ) announced that Emil Hjalmarsson has been appointed Chairman of the Nomination Committee. The Nomination Committee consists of: Christer Fåhraeus, Christer Fåhraeus with Companies; Nicklas Hansen, William Demant Invest A/S; Anette Andersson, SEB Investment funds and Emil Hjalmarsson, Grenlunden CEVI AB.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.5 SEK | -3.92% | -1.78% | +4.01% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 480M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-7.14% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- CEVI Stock
- News CellaVision AB
- CellaVision AB Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee